series-a
Stage
1
Investors
About
PulmoBioMed develops a non-invasive breath sampling device called PBM-Hale™, which collects deep lung samples without contamination from the mouth or environment. This technology enables faster, safer, and more accessible lung disease diagnosis, addressing the limitations of existing invasive methods.
Explore PulmoBioMed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.